These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22950071)

  • 1. Evaluation of the Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection.
    Shin S; Kim M; Kim M; Lim H; Kim H; Lee K; Chong Y
    Ann Lab Med; 2012 Sep; 32(5):355-8. PubMed ID: 22950071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a rapid membrane enzyme immunoassay for the simultaneous detection of glutamate dehydrogenase and toxin for the diagnosis of Clostridium difficile infection.
    Kim H; Kim WH; Kim M; Jeong SH; Lee K
    Ann Lab Med; 2014 May; 34(3):235-9. PubMed ID: 24790912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital.
    Babady NE; Stiles J; Ruggiero P; Khosa P; Huang D; Shuptar S; Kamboj M; Kiehn TE
    J Clin Microbiol; 2010 Dec; 48(12):4519-24. PubMed ID: 20943860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays.
    Pancholi P; Kelly C; Raczkowski M; Balada-Llasat JM
    J Clin Microbiol; 2012 Apr; 50(4):1331-5. PubMed ID: 22278839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the diagnostic performance of the xpert Clostridium difficile assay and its comparison with the toxin A/B enzyme-linked fluorescent assay and in-house real-time PCR assay used for the detection of toxigenic C. difficile.
    Whang DH; Joo SY
    J Clin Lab Anal; 2014 Mar; 28(2):124-9. PubMed ID: 24395702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.
    Tenover FC; Novak-Weekley S; Woods CW; Peterson LR; Davis T; Schreckenberger P; Fang FC; Dascal A; Gerding DN; Nomura JH; Goering RV; Akerlund T; Weissfeld AS; Baron EJ; Wong E; Marlowe EM; Whitmore J; Persing DH
    J Clin Microbiol; 2010 Oct; 48(10):3719-24. PubMed ID: 20702676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.
    Novak-Weekley SM; Marlowe EM; Miller JM; Cumpio J; Nomura JH; Vance PH; Weissfeld A
    J Clin Microbiol; 2010 Mar; 48(3):889-93. PubMed ID: 20071552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Clostridium difficile toxin A/B genes by multiplex real-time PCR for the diagnosis of C. difficile infection.
    Kim H; Jeong SH; Kim M; Lee Y; Lee K
    J Med Microbiol; 2012 Feb; 61(Pt 2):274-277. PubMed ID: 21959205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid diagnosis of Clostridium difficile infection by multiplex real-time PCR.
    Barbut F; Monot M; Rousseau A; Cavelot S; Simon T; Burghoffer B; Lalande V; Tankovic J; Petit JC; Dupuy B; Eckert C
    Eur J Clin Microbiol Infect Dis; 2011 Oct; 30(10):1279-85. PubMed ID: 21487764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the performance of C. DIFF QUIK CHEK COMPLETE and its usefulness in a hospital setting with a high prevalence of Clostridium difficile infection.
    Chung HS; Lee M
    J Investig Med; 2017 Jan; 65(1):88-92. PubMed ID: 27625418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of strain typing results for Clostridium difficile isolates from North America.
    Tenover FC; Akerlund T; Gerding DN; Goering RV; Boström T; Jonsson AM; Wong E; Wortman AT; Persing DH
    J Clin Microbiol; 2011 May; 49(5):1831-7. PubMed ID: 21389155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel target and PCR assay for identification of hypervirulent ST1 (BI/NAP1/027) Clostridioides difficile and detection of toxigenic C. Difficile.
    Li Z; Ouyang Z; Zhang H; Mi C; Dong N; Niu Y; Qiang C; Yang J; Wang W; Li Y; Zhao J
    Clin Chim Acta; 2024 Jun; 559():119728. PubMed ID: 38750779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multiplex, internally controlled real-time PCR assay for detection of toxigenic Clostridium difficile and identification of hypervirulent strain 027/ST-1.
    Hoegh AM; Nielsen JB; Lester A; Friis-Møller A; Schønning K
    Eur J Clin Microbiol Infect Dis; 2012 Jun; 31(6):1073-9. PubMed ID: 21938539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory diagnosis of Clostridium difficile infection: Comparison of Techlab C. diff Quik Chek Complete, Xpert C. difficile, and multistep algorithmic approach.
    Seo JY; Jeong JH; Kim KH; Ahn JY; Park PW; Seo YH
    J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28177534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance assessment of the BD MAX Cdiff assay in comparison to Xpert C. difficile assay in a setting with very low prevalence of toxigenic Clostridium difficile PCR ribotype 027.
    Chiang D; Ng S; La MV; Jureen R; Lin RT; Teo JW
    Anaerobe; 2014 Dec; 30():156-8. PubMed ID: 25305151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the illumigene C. difficile assay for toxigenic Clostridium difficile detection: a prospective study of 302 consecutive clinical fecal samples.
    Hong G; Park KS; Ki CS; Lee NY
    Diagn Microbiol Infect Dis; 2014 Nov; 80(3):177-80. PubMed ID: 25241189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter evaluation of the Verigene Clostridium difficile nucleic acid assay.
    Carroll KC; Buchan BW; Tan S; Stamper PD; Riebe KM; Pancholi P; Kelly C; Rao A; Fader R; Cavagnolo R; Watson W; Goering RV; Trevino EA; Weissfeld AS; Ledeboer NA
    J Clin Microbiol; 2013 Dec; 51(12):4120-5. PubMed ID: 24088862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an UltraFast LabChip V280 assay for detection of toxigenic Clostridium difficile.
    Xu X; Luo Y; Song X; Ying J; Ye J; Lu Y; Cai J; Ma J; Wang X; Yu W; Wang Y; Jin D
    Diagn Microbiol Infect Dis; 2018 Dec; 92(4):279-283. PubMed ID: 30029809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a new commercial TaqMan PCR assay for direct detection of the clostridium difficile toxin B gene in clinical stool specimens.
    Stamper PD; Babiker W; Alcabasa R; Aird D; Wehrlin J; Ikpeama I; Gluck L; Carroll KC
    J Clin Microbiol; 2009 Dec; 47(12):3846-50. PubMed ID: 19846637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of the STANDARD M10 and Xpert
    Lee H-W; Yu H-J; Kim H; Yun SA; Suh E; Kang M; Kim TY; Huh HJ; Lee NY
    J Clin Microbiol; 2024 Jul; 62(7):e0052424. PubMed ID: 38934589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.